Tenet Healthcare (THC1) AI Stock Analysis

2 Followers

Tenet Healthcare

(XETRA:THC1)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Ambulatory growth platformUSPI combines strong margins with expanding higher-acuity procedures and a pipeline of acquisitions, partnerships, and de novo centers. Continued migration toward freestanding ambulatory settings can support durable volume growth, physician engagement, and operating leverage over the next several quarters.

Negative Factors

Exchange and Medicaid exposureTenet remains exposed to policy-driven changes in insurance coverage and Medicaid reimbursement. Reduced exchange participation has already pressured volumes and uncompensated care, while potential work requirements could affect a large admission base and create persistent revenue and margin uncertainty.

Tenet Healthcare (THC1) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 23.26B
Dividend Yield: ―
Average Volume (3M): 16
Price to Earnings (P/E): 8.4
Beta (1Y): 0.43
Revenue Growth: 0.94%
EPS Growth: 124.21%
Country: Germany
Employees: 88,500
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Tenet Healthcare Business Overview & Revenue Model

Company Description

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care fac...

Tenet Healthcare Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:6.61%|Next Earnings Date:Feb 10, 2027

Earnings Call SentimentPositive

The call was strongly positive overall. Tenet delivered substantial earnings, margin, cash flow, and share-repurchase performance; raised its 2026 revenue, EBITDA, and free cash flow guidance; and expressed confidence in core EBITDA growth for 2027. The principal challenges were exchange-related volume and coverage pressure, lower USPI case volumes, the nonrecurring nature of Conifer transition contributions, and uncertainty surrounding Medicaid work requirements, HR 1, and future regulatory conditions.

Positive Updates

Strong Third-Quarter Financial Performance

Third-quarter net operating revenues were $5.6 billion and consolidated adjusted EBITDA was $1.355 billion. Adjusted diluted earnings per share increased 80% year over year to $6.40.

Negative Updates

Lower USPI Case Volumes

USPI same-facility case volumes declined 1.5% year over year, which management said reflected its focus on higher-acuity cases.

Company Guidance

For 2026, Tenet expects consolidated net operating revenues in the range of $22.05 to $22.45 billion, adjusted EBITDA in the range of $5.05 to $5.2 billion, and adjusted free cash flow after NCI in the range of $1.925 to $2.155 billion, including the payment of $150 million in tax payments this year for the Conifer transaction; excluding these tax payments, this would represent $2.2 billion of adjusted free cash flow after NCI at the midpoint of our 2026 outlook. Various transition activities at Conifer are expected to total $450 million of adjusted EBITDA in 2026, and these contributions are not expected to recur in 2027. After excluding the impact of the transition activities at Conifer, Tenet expects its enterprise to deliver overall adjusted EBITDA growth in 2027, assuming the current known regulatory frameworks; USPI should not be materially impacted by exchange headwinds and Medicaid work requirements, with same store revenue growth, consistent margins, and further expansion of the asset portfolio, while the hospital segment currently sees healthy patient demand that would support same store volume growth and a stable operating environment supported by disciplined cost controls.

Tenet Healthcare Risk Analysis

Tenet Healthcare disclosed 25 risk factors in its most recent earnings report. Tenet Healthcare reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Tenet Healthcare Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:THC1 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UHS	76Outperform	$10.44B	8.15	19.54%	0.41%	8.00%	13.14%
ARDT	69Neutral	$1.65B	12.49	5.21%	―	3.34%	-69.26%
HCA	64Neutral	$96.69B	16.87	-100.45%	0.60%	5.82%	16.59%
SGRY	59Neutral	$2.98B	-33.56	-5.21%	―	3.99%	51.58%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CYH	39Underperform	$289.10M	-0.62	36.02%	―	-7.84%	-88.93%

* Healthcare Sector Average

Performance Comparison

DE:THC1 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:THC1	Tenet Healthcare Corp.	258.00	82.00	46.59%
CYH	Community Health Systems	2.38	-1.39	-36.87%
HCA	Hca Healthcare	510.70	37.33	7.89%
UHS	Universal Health Services	196.46	-31.78	-13.92%
SGRY	Surgery Partners Inc.	23.16	1.66	7.72%
ARDT	Ardent Health Partners, Inc.	12.99	-1.41	-9.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Tenet Healthcare AI Stock Analysis